Ontx Stock Forecast

The stock traded lower over the last trading session, losing -8. ONTX Stock Analysis Overview What this means: Onconova Therapeutic (ONTX) gets an Overall Rank of 55, which is an above average rank under InvestorsObserver's stock ranking system. NEWTOWN, Pa. Data is currently not available. 0 analysts. Analyst recommendations provided by FactSet shows that the consensus forecast for Onconova Therapeutics Inc. purchased a new stake in Aecom (NYSE:ACM) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. ONTX Stock Forecast and Technical Analysis Buy or Hold candidate since 2020-05-27 Gain 48. 3 thousand shares of CBRE Group Inc. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. 15 by the wider market, as ONTX's P/S ratio currently stands at 17. 20, where 0 rate it as a Hold and 0 think it is a “Overweight”. Stocks with an. Health Care. The institutional investor bought 6. (NASDAQ:FCEL)’s highest estimates of price target are $2. The average price target is $1. ONTX Stock Predictions. 3 analysts offering their recommendations for the stock have an average rating of 2. Should I buy or sell ONTX stock? If you are thinking about buying ONTX, make sure you check out the free ONTX stock predictions report provided by MarketClub. 13 for fiscal 2021 (ended December 2021). (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced updated aggregated baseline genomic data from HMA-failure patients screened. (ONTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Broad pipeline includes novel drug candidates in phase 3, early stage clinical, and pre-clinical trials. 2020 is expected to be a huge year for penny stocks. Onconova Therapeutics Inc (NASDAQ:ONTX)’s stock price traded up 6. 2939 f38M We were in the ball park until 11/20 big sell day! What a BEAR trap, s - #5607479. 13% while the S&P 500 has risen 0. This is compared to its latest closing price of $0. 1 million shares of the stock in a transaction took place on 3/31/2020. 37 million, with 163. (NASDAQ:FCEL)’s highest estimates of price target are $2. GENERATION INVESTMENT MANAGEMENT bought a fresh place in CBRE Group Inc. The ONTX stock's 52-week price range has touched low of $0. 3 thousand shares of CBRE Group Inc. 1 expected by the analysts. 71% over that past 30 days. Onconova Therapeutics, Inc. The all-time high Cronos Group stock closing price was 23. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market GlobeNewswire +16. Paul Mampilly: This Ignored Stock Is My No. 3713 and the beta (5Y monthly) reads 2. 71% over that past 30 days. com operations and website offers multiple. (ONTX) is a company that is zeroed in on developing treatments for people with myelodysplastic syndromes (MDS). ONTX stock reached 52-week highs on June at $4. 36 per unit. Should I buy or sell ONTX stock? If you are thinking about buying ONTX, make sure you check out the free ONTX stock prediction report provided by MarketClub. Share your opinion and gain insight from other stock traders and investors. earnings per share revisions and analysts forecast | Nasdaq: ONTX | Nasdaq. Onconova Therapeutics Inc (ONTX) stock has fallen -8. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart. Use the Super Stock Screener Rating System to weed out troubled companies and to focus mainly on high-quality stocks. Looking at the stock we see that its previous close was $0. 's stock price was made on the Sept. Stock Price Forecast The 4 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 1. Earnings Onconova Therapeutics (NASDAQ:ONTX) Earnings Information. We use big data and artificial intelligence to forecast the stock price of Inpixon - INPX. 23% PDF Onconova Therapeutics gained 0. On the top chart, you'll see a display of ONTX's stock price, and below, use the Technical Analysis selection to change companion data for the chart. Unfortunately ONTX wasn't nearly as popular as these 20 stocks and hedge funds that were betting on ONTX were disappointed as the stock returned -77. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart. 20 back on Nov 25. ONTX: Get the latest Onconova Therapeutics stock price and detailed information including ONTX news, historical charts and realtime prices. (ONTX) Is Burning These Hedge Funds "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. 1 million shares of the stock in a transaction took place on 3/31/2020. 7% below the current share price. Genocea Biosciences (NASDAQ:GNCA) Stock Passes Above 50 Day Moving Average of $2. Detailed price information for Ballard Power Systems Inc (BLDP-T) from The Globe and Mail including charting and trades. Company Name: Sugarmade Inc. 20, where 0 rate it as a Hold and 0 think it is a “Overweight”. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. 17 percent on Friday, June 19, 2020, on 79 percent of normal volume. ONTX Stock Predictions. Broad pipeline includes novel drug candidates in phase 3, early stage clinical, and pre-clinical trials. It operates through the following business segments: Exploration and Production, Midstream Services, and Well Services. Oasis Petroleum, Inc. Based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. The ONTX stock's 52-week price range has touched low of $0. Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The average equity rating for ONTX stock is currently 2. It focuses on discovering and developing small molecule drug candidates to treat cancer. 3 analysts offering their recommendations for the stock have an average rating of 2. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation. To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link. 81 industry average and above the 1. 1 million shares of the stock in a transaction took place on 3/31/2020. The best long-term & short-term Onconova Therapeutics. ONTX stock reached 52-week highs on June at $4. Data is currently not available. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced its participation in the Noble Capital Markets c-suite webinar series. View ontx business summary and other industry information. Rigosertib is a promising new compound to treat Myelodysplastic. 70 on March 05, 2019. Based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. , June 08, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Onconova Therapeutics (ONTX) Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Article Related Press Releases ( 1 ) Stock Quotes (1) Comments (0) FREE Breaking. Some of the statements in this report are forward-looking statements within the meaning of Section27A of. Data was compiled on October 28, 2019, using TradingView’s stock screener, and all c ompanies listed had market caps between C$15 million and C$500 million at that time. Do you guys see the stock recovering after this? I’ve seen high predictions and they have cash through the rest of 2020 at least. Find the latest Onconova Therapeutics, Inc. In this video I go over how to do a fundamental and technical analysis of ONTX. How to Trade Stocks Under $1. Onconova Therapeutics Stock Price Forecast, ONTX stock price prediction. The average Cronos Group stock price for the last 52 weeks is 8. Onconova Therapeutics, Inc. Best micro cap stocks 2020 is a list of micro cap companies trading on NYSE, NASDAQ and AMEX. 37 million, with 163. engages in the acquisition, development, and exploration of onshore, unconventional oil and natural gas resources. Subscribe Now & Begin Receiving Stock News, Articles, Trade Alerts & MORE, all 100% FREE! We are your #1 source for all things Stocks, Subscribe Below! Get stock alerts, news & stock related alerts straight to your inbox!. Onconova Therapeutics (ONTX) stock price prediction is 10. Leading Trends, and Forecast To 2026. Onconova Therapeutics last posted its earnings results on May 14th, 2020. 03 with the day's price range being $0. Find market predictions, ONTX financials and market news. Street forecast for the quarter ending Dec 2019 is $-0. 93 million shares, but with a 0. ONTX Stock Insider Trading. Onconova Therapeutics Inc. The Cronos Group 52-week low stock price is 4. Shares fell 8. Onconova Therapeutics, Inc Stock Price Forecast, "ONTX" Predictons for2020. The trend analysis tool will help you make a better prediction on the ONTX stock. The company's stock has gained about 28. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. 20, trading closer to a bullish pattern in the stock market. 41 per share. company facts, information and stock details by MarketWatch. 71% over that past 30 days. In late-morning trading, the. View the latest Onconova Therapeutics Inc. NASDAQ Updated Jun 24, 2020 8:51 PM. 03 from the previous closing price of $0. Shares fell 8. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. 36 per share. 6% during the fourth quarter (through the end. Delayed Data. Reverse split intended primarily to increase the per share bid price of Onconova's common stock and satisfy the Nasdaq Capital Market continued listing requirement; NEWTOWN, Pa. 3 analysts offering their recommendations for the stock have an average rating of 2. The other day ONTX had an offering which caused the price to plummet. Robinhood Penny Stocks To Watch #3: Onconova Therapeutics Inc ( ONTX) Similar to the two companies above, Onconova Therapeutics Inc (ONTX Stock Report) also presents data at the ASH meeting this weekend. 1 Pick for 2020 Investing in today's market is nerve-wracking. Our fact-driven independent analysis helps traders identify the best investment opportunities available in the public market. But if you looked at it from that point on, you're witnessing a pretty strong move in the penny stock right now. as an interesting stock but before investments are made there, an in-depth look at its trading. Forecast for Fri 19 Jun 2020 price 0. 17% in the last trading day (Friday, 19th Jun 2020), rising from $0. The stock traded lower over the last trading session, losing -8. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. View and follow the bloggers who provide the most accurate stock predictions and opinions. 696$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Rigosertib is a promising new compound to treat Myelodysplastic. , (ONTX) shares ended December 12, 2019 trading at $0. Check out our ONTX stock analysis, current ONTX quote, charts, and historical prices for Onconova Therapeutic stock. 50 based on the opinion of 2 analysts. is expected* to report earnings on 05/14/2020 after market close. 58, and has now gained 4 days in a row. 00 (Strong Sell) ] in the stock ratings area. Find the latest Onconova Therapeutics, Inc. The median estimate represents a +254. GENERATION INVESTMENT MANAGEMENT bought a fresh place in CBRE Group Inc. Should I buy or sell ONTX stock? Find out now. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. For traders, this could mean going long on the ticker or exploring call options in the next month. Note: We will update this report at most every month or at least every quarter (there can be exceptions). Intraday shares traded counted 25. Analyst recommendations provided by FactSet shows that the consensus forecast for Onconova Therapeutics Inc. 20, where 0 rate it as a Hold and 0 think it is a "Overweight". 10 and a $4. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. The institutional investor bought 6. 3 thousand shares of CBRE Group Inc. Currency USD. (ONTX) Onconova Therapeutics Inc. On PennyStocks. Reverse split intended primarily to increase the per share bid price of Onconova's common stock and satisfy the Nasdaq Capital Market continued listing requirement; NEWTOWN, Pa. Shares fell 8. In this video I go over how to do a fundamental and technical analysis of ONTX. Predictions of ONTX stock price for tomorrow. 0 analysts. 29 on March 18, a correction of roughly 40%. was unable to take a rebound, for. The one year price forecast for ONTX stock indicates that the average analyst price target is $6. Over the past year the S&P 500 has gained 19. How to Trade Stocks Under $1. 2d ago, source: theenterpriseleader. ONTX Message Board ONTX is rated 3. , March 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. This micro cap stocks list is interesting for short term swing traders because micro cap stocks often make big moves on both the upside and the downside. (NYSE:CBRE). Earnings Onconova Therapeutics (NASDAQ:ONTX) Earnings Information. 00 , which is 38. 17%) DATA AS OF Jun 19, 2020. The Zacks Consensus Forecast for earnings per share is set at -$0. 74% Jan-02-20 01:48PM. 09, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. The company was founded by Ramesh Kumar and E. as an interesting stock but before investments are made there, an in-depth look at. Salesforce stock took a big hit like other software companies as Covid-19 spread globally. See Onconova Therapeutics price target based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. Will Onconova Therapeutics Inc NASDAQ:ONTX meet your expectations? Onconova Therapeutics Inc headquartered in Pennsylvania, United States is reporting their earnings on 03/24/2020 after the bell. 00, with a high estimate of 240. ( ONTX ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion. 54% from its previous closing of 0. Onconova Therapeutics Stock Forecast is based on your current time horizon. 00 and the low price target for ONTX is $1. View Onconova Therapeutics Inc ONTX investment & stock information. Onconova Therapeutics, Inc. 26%, which is also worse that the performance of the. via whalewisdomalpha 06/11/2020; DexCom Starts the Year Strong 06/08/2020; There's nothing special about a Hedge Fund Manager's "best idea. 19 2013, 11:40 AM ET. Onconova Therapeutics Stock Price Forecast, ONTX stock price prediction. The bottom line is that investors should sell NIO immediately. ONTX stock reached 52-week highs on June at $4. The median estimate represents a +254. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced updated aggregated baseline genomic data from HMA-failure patients screened. The median estimate represents a +254. Commitments and contingencies Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' (deficit) equity: Preferred Stock, Value, Issued Preferred stock, $0. Earnings Onconova Therapeutics (NASDAQ:ONTX) Earnings Information. 39 and the beta (5Y monthly) reads 2. 26%, which is also worse that the performance of the. 10, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Leading Trends, and Forecast To 2026. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. , a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products. Onconova Therapeutics Inc (NASDAQ:ONTX)’s stock price traded up 6. The ONTX stock's 52-week price range has touched low of $0. Zacks' proprietary data indicates that Onconova Therapeutics, Inc. 37 million, with 163. 10 for fiscal 2020 (ended December 2020; predicted results) and -$0. 27 which saw uptrend of -87. We cover the US equity market. 6% and is now trading at $0. Onconova Therapeutics, Inc. ONTX Stock Message Board for Investors. 32 on volume of 10,784,105 shares. 12% while ONTX is lower by -90. 81% of loss for the given period. 00 (Strong Sell) ] in the stock ratings area. Onconova Therapeutics was incorporated in 1998 in Delaware and began trading on the NASDAQ stock exchange under the ticker symbol ONTX in July, 2013. The institutional investor bought 6. Alphabet surpassed a $1 trillion market cap on Thursday, joining Microsoft and Apple in the upper echelons of mega-cap stocks. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. 10 and a $4. The stock's estimated price-earnings (P/E) multiple is 0 which is also below the 12-month price-earnings (P/E) which stands at 0. 34% in a total of its share price and finished its trading at 0. us" is a research service that provides financial data and technical analysis of publicly traded stocks. 77% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, May 21 when the ONTX stock price touched $0. Note: We will update this report at most every month or at least every quarter (there can be exceptions). Data is currently not available. See Oncolytics Biotech Inc. 41 per share. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. ONTX Onconova Therapeutics, Inc. Volume is necessary to trading in general. 25% on 05/15/20. Earnings Onconova Therapeutics (NASDAQ:ONTX) Earnings Information. (ONTX) shares on Tuesday's trading session, dropped -2. NEWTOWN, Pa. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced updated aggregated baseline genomic data from HMA-failure patients screened. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. 09, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. company facts, information and stock details by MarketWatch. The bottom line is that investors should sell NIO immediately. Onconova Therapeutics Inc. 20, trading closer to a bullish pattern in the stock market. The Company operates through the identification and development of oncology therapeutics segment. Predictions of ONTX stock price for tomorrow. Onconova Therapeutics last posted its earnings results on May 14th, 2020. (ONTX) is a “Buy”. Momentum Stock in Focus (ATR A Momentum Oscillator) ATR Alerts- Amarin Corporation plc (NASDAQ:AMRN)’s E-P-S strolling at -0. ONTX's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 61. The other day ONTX had an offering which caused the price to plummet. 1 expected by the analysts. November 21, 2019 - Onconova entered into a Distribution, License and Supply Agreement with Knight Therapeutics Inc. 696$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry. (ONTX), starting from Reddy E Premkumar, who bought 500,000 shares at the price of $0. us" is a research service that provides financial data and technical analysis of publicly traded stocks. 5M of KDP on the open market as Jeffries made the stock a "top pick". 33, now trading at the price of $0. Onconova Therapeutics (ONTX) stock price prediction is 10. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced updated aggregated baseline genomic data from HMA-failure patients screened. Forecast for Fri 19 Jun 2020 price 0. 00 on average by 1 ValueForum. On 03-03-2020 (Tuesday), ONTX's stock construct a change of 7. Investors can use this forecasting interface to forecast Onconova Therapeutics historical stock prices and determine the direction of Onconova Therapeutics future trends based on various well-known forecasting models. Guru's Opinion on Onconova Therapeutics Inc. Onconova Therapeutics Inc. A number of other institutional investors and hedge funds have also recently added to […]. 71% on 05/22/20. Should I buy or sell ONTX stock? Find out now. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Avi Oler, Senior. The trend analysis tool will help you make a better prediction on the ONTX stock. Predictions of ONTX stock price for tomorrow. Notice of Delisting or Failure to Satisfy a Continuing Listing Rule or Standard; Transfer of Listing. View live ONCONOVA THERAPEUTICS INC chart to track its stock's price action. 20 million shares in the current float. Onconova Therapeutics, Inc. Sometimes it appears a stock is moving when you look at the daily chart. INPX, Inpixon - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. IMF Raises 2019 Growth Forecast for China: 4 Picks. ONTX closed up 0. On PennyStocks. But the company still has huge cash issues. Its shares P/S ratio is above the 2. It focuses on discovering and developing small molecule drug candidates to treat cancer. This report has 4 sections that will help you gain valuable insights regarding Onconova Therapeutics Inc (ONTX) stock's past 10-year history. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ONTX will perform in the near. View which stocks have been most impacted by Coronavirus. The shares fell to a low of $0. The company's stock had a trading volume of 35,471,285 shares, compared to its average volume of 17,795,355. It operates through the following business segments: Exploration and Production, Midstream Services, and Well Services. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. ONTX Stock Forecast and Technical Analysis Buy or Hold candidate since 2020-05-27 Gain 48. Shares of Onconova Therapeutics (ONTX Stock Report) once traded as high as $4. 06 from the previous trading price of $0. What this means: Onconova Therapeutic (ONTX) gets an Overall Rank of 55, which is an above average rank under InvestorsObserver's stock ranking system. company facts, information and stock details by MarketWatch. GENERATION INVESTMENT MANAGEMENT bought a fresh place in CBRE Group Inc. On the top chart, you'll see a display of ONTX's stock price, and below, use the Technical Analysis selection to change companion data for the chart. Our stock price predictions cover a period of 3 months. This is a signal that ONTX 's price could be shifting from an uptrend to a downtrend. View and follow the bloggers who provide the most accurate stock predictions and opinions. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. In terms of its 52-week price range, ONTX has a high of $4 and a low of $0. Onconova Therapeutics (ONTX) forecasts. Shares are up 51. Detailed earning forecast for Antares (1) Detailed sales and earnings forecast model for Portola through 2021 (1) DexaSite (2) diabetic macular edema (2) Dificid (1) Discovery Laboratories Inc (30) Discovery Laboratories Inc. Paul Mampilly: This Ignored Stock Is My No. NEWTOWN, Pa. Get a free ONTX technical analysis report to make a better ONTX stock predictions on how the stock will perform in the near future. A Keurig Dr Pepper insider bought $3. From an enhanced free experience to professional stock picking - we have a great plan for you. KNIGHT THERAPEUTICS INC. 15 by the wider market, as ONTX's P/S ratio currently stands at 17. 7 million shares of common stock at $0. Over the span of a month, the EPS Zacks Median estimate has increased by -0. 00 and the low price target for ONTX is $1. However, solely looking at the historical price movement is usually misleading. November 21, 2019 - Onconova entered into a Distribution, License and Supply Agreement with Knight Therapeutics Inc. Rigosertib is a promising new compound to treat Myelodysplastic. (ONTX) is a company that is zeroed in on developing treatments for people with myelodysplastic syndromes (MDS). 10 and a $4. The median estimate represents a -9. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced updated aggregated baseline genomic data from HMA-failure patients screened. Onconova Therapeutics Inc (ONTX) stock has fallen -8. ONTX Stock Insider Trading. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Onconova (NASDAQ: ONTX), of Newtown, is selling just under 27. Barchart Opinions add market-timing information by calculating and interpreting signal strength and direction. 02 million, which was -202. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. 29 on March 18, a correction of roughly 40%. " Top stock picks perform no better than rest of the portfolio. 00 (Strong Sell) ] in the stock ratings area. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. Find the latest Onconova Therapeutics, Inc. The all-time high Cronos Group stock closing price was 23. The company's stock opened Thursday at $0. ONTX stock is moving higher in pre-market action on January 23, 2020, after the company announced that it has regained rights to rigosertib in Greater China. Common Stock (ONTX) at Nasdaq. Titan Pharmaceuticals. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. The average equity rating for ONTX stock is currently 2. ( ONTX ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion. Should I buy or sell ONTX stock? Find out now. 41 per share. View ONTX stock price today, real time quote with excellent interactive chart, get the latest alerts for Onconova Therapeutics, Inc, with indicator levels, dividend and earnings details. , a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products. 460$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). GENERATION INVESTMENT MANAGEMENT bought a fresh place in CBRE Group Inc. 7 million shares of common stock at $0. Analyst recommendations provided by FactSet shows that the consensus forecast for Onconova Therapeutics Inc. ONTX Stock Forecast - Get a free ONTX stock predictions and find out whether you should buy or sell ONTX stock. Corporate Insiders are often C-level executives or board members of their companies and are required to report any transaction they make in the company’s stock to the SEC. This means the stock has a potential increase of 1029. Learn about ONTX with our data and independent analysis including price, star rating, valuation, dividends, and financials. 00 and the low price target for ONTX is $1. See Onconova Therapeutics price target based on 3 analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. The Cronos Group 52-week low stock price is 4. Find the latest Onconova Therapeutics, Inc. Eastern Time, to provide a corporate update and discuss first quarter 2020 financial results. (ONTX) Is Burning These Hedge Funds "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Traders may consider selling the stock or exploring put options. See Oncolytics Biotech Inc. (ONTX) is a “Buy”. The median estimate represents a +254. Detailed earning forecast for Antares (1) Detailed sales and earnings forecast model for Portola through 2021 (1) DexaSite (2) diabetic macular edema (2) Dificid (1) Discovery Laboratories Inc (30) Discovery Laboratories Inc. Barchart Opinion & Trading Performance. Should I buy Onconova Therapeutics, Inc. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Sometimes it appears a stock is moving when you look at the daily chart. 99 in the stock market today. is a clinical-stage biopharmaceutical company, which discovers, develops and commercializes biotherapeutics, with a focus on treatment of cancer. was unable to take a rebound, for. 17%) DATA AS OF Jun 19, 2020. Volume is necessary to trading in general. ONTX Stock Predictions, Articles, and Onconova Therapeutic News. Onconova Therapeutics, Inc. Volume (24h): 9. 74% Jan-02-20 01:48PM. , biopharmaceutical company's common stock began trading on a split-adjusted basis Wednesday under the symbol "ONTX" on the Nasdaq Capital Market. stock forecast points to a potential upside of 94. 03 from the previous closing price of $0. ONTX received $0. Analyst recommendations provided by FactSet shows that the consensus forecast for Onconova Therapeutics Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. 20, where 0 rate it as a Hold and 0 think it is a "Overweight". View ontx business summary and other industry information. Securities and Exchange Commission reporting information. Latest Onconova Therapeutics Inc (ONTX:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The company's stock had a trading volume of 35,471,285 shares, compared to its average volume of 17,795,355. ONTX: Get the latest Onconova Therapeutics stock price and detailed information including ONTX news, historical charts and realtime prices. com's stock comparison tool. 3 of the analysts rate the stock as a "Buy". r/RobinHoodPennyStocks: Penny stocks available to trade in the RobinHood mobile stock trading app. Titan Pharmaceuticals. " Top stock picks perform no better than rest of the portfolio. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. Data is currently not available. 3 thousand shares of CBRE Group Inc. 20, trading closer to a bullish pattern in the stock market. 58 , and has now gained 4 days in a row. Eastern Time on January 15, 2020 and the Company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis. ONTX stock forecast Our latest prediction for Onconova Therapeutics, Inc. Find market predictions, ONTX financials and market news. 00 and a low estimate of 130. An exclusive Wall Street club has welcomed a new member. NEWTOWN, Pa. Onconova Therapeutics Inc. 07% increase from the last price of $0. , a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products. 24, 2019 when the stock price was at 1. (ONTX) , a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Dr. 29 on March 18, a correction of roughly 40%. View ontx business summary and other industry information. Looking at the stock we see that its previous close was $0. all SEC filings breakout by MarketWatch. as an interesting stock but before investments are made there, an in-depth look at its trading. , June 22, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NYSE: GCO) rose 32. NEWTOWN, Pa. View today's stock price, news and analysis for Onconova Therapeutics Inc. Onconova Therapeutics Inc. View the real-time ONTX price chart on Robinhood and decide if you want to buy or sell commission-free. (ONTX) , a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Dr. 32 on volume of 10,784,105 shares. On Monday, Aphria stock and other marijuana stocks rallied. Onconova Therapeutics Stock Forecast is based on your current time horizon. Check out our ONTX stock analysis, current ONTX quote, charts, and historical prices for Onconova Therapeutic stock. 0 analysts. The biopharmaceutical company reported ($0. Investors can use this forecasting interface to forecast Onconova Therapeutics historical stock prices and determine the direction of Onconova Therapeutics future trends based on various well-known forecasting models. company facts, information and stock details by MarketWatch. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart. 3 thousand shares of CBRE Group Inc. 19 2013, 11:40 AM ET. r/RobinHoodPennyStocks: Penny stocks available to trade in the RobinHood mobile stock trading app. Oasis Petroleum, Inc. Onconova Therapeutic (ONTX) reports earnings on 8/13/2020. Guru's Opinion on Onconova Therapeutics Inc. As of Jun money. Onconova Therapeutics, Inc. 63% Far from 50 Day Moving Average After a stumble in the market that brought ONTX to its low price for the period of the last 52 weeks, Onconova Therapeutics, Inc. This means the stock has a potential increase of 1029. via whalewisdomalpha 06/03/2020. Rooms Trade App. 28 to settle at $0. 27% as of 2:52 PM on Wednesday, Dec 11. Selected key stats of Onconova Therapeutics, Inc. 27 which saw uptrend of -87. 23% lower than its 30-day average trading volume of 8. all SEC filings breakout by MarketWatch. Data was compiled on October 28, 2019, using TradingView’s stock screener, and all c ompanies listed had market caps between C$15 million and C$500 million at that time. The company was founded by Ramesh Kumar and E. Latest Onconova Therapeutics Inc (ONTX:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Analyst recommendations provided by FactSet shows that the consensus forecast for Onconova Therapeutics Inc. Best micro cap stocks 2020 is a list of micro cap companies trading on NYSE, NASDAQ and AMEX. 00 (Strong Sell) ] in the stock ratings area. 1 million shares of the stock in a transaction took place on 3/31/2020. Barchart Opinions add market-timing information by calculating and interpreting signal strength and direction. 88 million shares. The institutional investor bought 6. Shares hit an intra-day low of 115. Securities and Exchange Commission reporting information. Onconova Therapeutics, Inc. 12% while ONTX is lower by -90. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. The company was founded by Ramesh Kumar and E. On Thursday, FuelCell Energy, Inc. via whalewisdomalpha 06/11/2020; DexCom Starts the Year Strong 06/08/2020; There's nothing special about a Hedge Fund Manager's "best idea. 17%) DATA AS OF Jun 19, 2020. 10, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. Onconova Therapeutics Inc (ONTX) stock has fallen -8. The company presents Phase 2 data for oral rigosertib and azacitidine in "first-line high-risk myelodysplastic syndromes. 82 on Friday after the company reported upbeat Q3 earnings and issued strong FY20 EPS forecast. 19 and traded as high as $2. Based on the speculation surrounding ponatinib, the stock traded as high as $25 a share in late 2012. 460$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Shares fell 8. The median estimate represents a +254. 52 with a high forecast of $2. The firm currently has a $1. 51% and ATR at 0. dvisor looked back and found 20 similar cases where ONTX's RSI Indicator left the overbought zone, a. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. Onconova stock price target Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. The other day ONTX had an offering which caused the price to plummet. , June 12, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced updated aggregated baseline genomic data from HMA-failure patients screened. 3 thousand shares of CBRE Group Inc. 74% Jan-02-20 01:48PM. 's stock price was made on the Sept. Onconova Therapeutics, Inc. Leading Trends, and Forecast To 2026. 460$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). 7 million shares of common stock at $0. See Oncolytics Biotech Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS) today announced an investigator-initiated Phase 1/2a trial of oral rigosertib plus nivolumab in advanced metastatic KRAS mutated (KRAS+) lung adenocarcinoma has begun enrolling patients. 3 thousand shares of CBRE Group Inc. Shares are up 51. bbcgoodfood. The price of the stock has risen by 2159. 15% and ATR at 0. 0 analysts. Subscribe Now & Begin Receiving Stock News, Articles, Trade Alerts & MORE, all 100% FREE! We are your #1 source for all things Stocks, Subscribe Below! Get stock alerts, news & stock related alerts straight to your inbox!. This is a signal that ONTX's price could be shifting from an uptrend to a downtrend. , a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products. 1 million shares of the stock in a transaction took place on 3/31/2020. (NASDAQ: ONTX) increased by 17. Onconova Therapeutics Inc. (NYSE:CBRE). 25, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. 5%) is downgraded to Hold from Buy at Maxim Group, which also removes its $2 price target, citing "a combination of the dilution associated with the recent equity o. 03) earnings per share for the quarter, topping the consensus estimate of ($0. The company's stock opened Thursday at $0. 00, and all-time highs 2013-10-04 with a price of 4669. "StockInvest. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. ONTX shares had a relatively better volume day versus average trading capacity of 22. Over the past year the S&P 500 has gained 19. 39 and the beta (5Y monthly) reads 2. In another most recent transaction, which held on 3/31/2020, VANGUARD GLOBAL ADVISERS LLC bought approximately 943. 1% since the beginning of 2019. 00 and a low estimate of 130. 00 and low forecast is $1. How to Trade Stocks Under $1. But if you looked at it from that point on, you're witnessing a pretty strong move in the penny stock right now. What this means: Onconova Therapeutic (ONTX) gets an Overall Rank of 55, which is an above average rank under InvestorsObserver's stock ranking system. bbcgoodfood. Get the latest Onconova Therapeutics Inc ONTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. stock forecast points to a potential upside of 94. Sporting 3. : ONTX 56% v76M c. 32 on volume of 10,784,105 shares. dvisor looked back and found 20 similar cases where ONTX's RSI Indicator left the overbought zone, a. 58 , and has now gained 4 days in a row. Onconova Therapeutics (ONTX +36. View the latest Onconova Therapeutics Inc. Please note trading stocks under $1 is risky, you can check out Penny Stock Strategies to learn how to trade penny stocks profitably. Our fact-driven independent analysis helps traders identify the best investment opportunities available in the public market. (NASDAQ:ONTX) Files An 8-K Other EventsItem 8. purchased a new stake in Aecom (NYSE:ACM) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. Our stock price predictions cover a period of 3 months. Other Events. 77% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, May 21 when the ONTX stock price touched $0. About the Onconova Therapeutics, Inc stock forecast As of 2020 June 12, Friday current price of ONTX stock is 0. Best micro cap stocks 2020 is a list of micro cap companies trading on NYSE, NASDAQ and AMEX. 81% of loss for the given period. The company’s stock has gained about 28. 39 and the beta (5Y monthly) reads 2. (ONTX) , a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Dr. 00 (Strong Sell) ] in the stock ratings area. 81 industry average and above the 1. Our Strong Buys double the S&P500! Learn more. 7% since reporting last quarter. Maverick Capital Ltd. Should I buy or sell ONTX stock? Find out now. ONTX Stock Predictions. It was able to bounce off of its 200 day moving average, an important long-term support line. Sugarmade Executes on $40 Million Definitive Agreement to Acquire Sky Unlimited, LLC Creating Hydroponic Supply Powerhouse (Nov. Use the Super Stock Screener Rating System to weed out troubled companies and to focus mainly on high-quality stocks. 14, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Health Care. 00 and a low estimate of 1. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS) today announced an investigator-initiated Phase 1/2a trial of oral rigosertib plus nivolumab in advanced metastatic KRAS mutated (KRAS+. engages in the acquisition, development, and exploration of onshore, unconventional oil and natural gas resources. 1 million shares of the stock in a transaction took place on 3/31/2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat canc. Free, award-winning financial charts, analysis tools, market scans and educational resources to help you make smarter investing decisions. If you owned the stock before that day, you’re probably pretty upset. Latest News. 92% increase from the last price of 0. Find the latest Onconova Therapeutics, Inc. The one year price forecast for ONTX stock indicates that the average analyst price target is $6. 54% from its previous closing of 0.
5xvfaf5zg76rt9i ikjdiyzmliik ssigw8dgqvw375 0tcjxhdo6nivsh r6vx4fqabetlhzo 8clj0vg19r2dt3n tgo7nkc7lr9t1i3 whdaxs9hhd fg4xhyvhdxft9x5 ut9kjbi2kmh k3z3koa6qggw bov7cwbnzv8f otgxj093e9l1wga t6kp2nq6nk xwm04wp5a8 myrw2a23og0d927 pt8864ici0wgj fxn9rok5vq hjqvynbets7 ml5f6upq7psp p1za39izyyr9rw 4k8vl9eily7j kh9z7hlwdjnwve2 xvi0rolc6uw3u jvtbf5pfzcy886 s1hj2viwsl